The U.S. advanced wound care market was valued at $3.35 billion in 2019 and is expected to climb to $4.97 billion by 2027, registering a CAGR of 9.9% from 2020 to 2027. Rising incidences of diabetes, obesity, and other chronic conditions, combined with a growing geriatric population and increasing demand for faster and more effective wound healing solutions, are collectively propelling market growth across the country.
Access Sample Data & Findings: https://www.alliedmarketresearch.com/request-sample/A06638
Advanced wound care solutions have emerged as a preferred alternative to traditional wound care methods, driven by their enhanced efficiency and effectiveness in managing both chronic and acute wounds. Unlike conventional products, advanced wound care therapies function on the principle of moisture therapy, maintaining a hydrated wound environment to facilitate faster cellular regeneration. These products also help regulate wound temperature, facilitate oxygen flow, relieve pain associated with dressing changes, and provide strong protection from exogenous infection.
Traditional wound care products such as hydrocolloids, hydrogels, film and foam dressings, and alginates are increasingly being replaced by advanced alternatives owing to their demonstrably superior outcomes in wound management. Nearly 15% of Medicare beneficiaries experience a chronic wound or infection each year according to available studies, with the most common chronic wounds arising from diabetes and venous or arterial insufficiency, underscoring the urgency and scale of unmet clinical need in this segment.
The therapy devices segment held the largest product share in 2019, driven by the rising incidence of chronic diseases such as diabetes and obesity and a growing demand for innovative wound care products. Key therapy device categories include negative pressure wound therapy, oxygen and hyperbaric oxygen equipment, and electromagnetic therapy devices, all of which are experiencing strong adoption across hospital and outpatient settings.
The chronic wounds application segment is projected to exhibit the highest CAGR during the forecast period, fueled by a surge in post-operative surgical wounds, rising geriatric population, increasing diagnostic awareness, and continuous technological advancement in wound care product portfolios. High cost of advanced wound care products remains a key restraint, though intensifying focus on evidence-based treatment protocols and innovative product development is creating fresh expansion opportunities for market players.
★ See What’s Inside This Report @ https://www.alliedmarketresearch.com/purchase-enquiry/A06638
MARKET SNAPSHOT
- Market Value in 2019: $3.35 Billion
- Projected Market Value by 2027: $4.97 Billion
- Growth Rate: CAGR of 9.9% from 2020 to 2027
- Dominant Product Segment: Therapy Devices, led by NPWT and hyperbaric oxygen equipment
- Fastest Growing Application: Chronic Wounds including diabetic foot ulcers and pressure ulcers
- Key Growth Drivers: Rising diabetes, obesity, geriatric population, and chronic wound burden
- Core Product Categories: Infection Management, Exudate Management, Active Wound Care, Therapy Devices
- Key End-User Segments: Hospitals and Community Health Service Centers
- Market Restraint: High cost of advanced wound care products
- Key Market Players: 3M (Acelity), Johnson & Johnson, Medtronic, Smith & Nephew, ConvaTec, Coloplast
KEY TAKEAWAYS
The U.S. advanced wound care market study spans detailed segment analysis by product, application, and end user across the forecast period from 2020 to 2027. More than 1,500 product literature pieces, industry releases, annual reports, and related documents from major market participants were reviewed alongside authentic industry journals, trade association publications, and government websites to generate high-value insights. The study integrates high-quality data, expert opinions, and independent analytical perspectives to deliver a balanced and actionable view of the U.S. advanced wound care landscape.
The report is structured to help stakeholders identify prevailing market opportunities, benchmark against leading competitors, and formulate region-specific strategies for sustainable growth in this rapidly evolving segment of the healthcare industry.
About Us
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides end-to-end solutions along with information, education, advocacy, and networking resources to SMEs and early-stage start-ups to bring excellence to their processes. In addition, we offer a nurturing environment required to develop and grow businesses, including business planning; virtual support; market intelligence; acquiring resources; and getting direct access to finance, suppliers, and other experts to boost the growth of businesses and entrepreneurs.
Our bundled and hassle-free business support systems are customized to meet the needs of SME consultants and industry leaders. Moreover, our large network of skilled consultants and experts help start-ups get the business on a roll.
Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
